Login to Your Account

PPARs Show Diabetes Promise; Regulator Caution Slows Work

By Randall Osborne

Monday, July 19, 2004
Among the army of acronyms that marches across the pages of biomedical research reports is PPAR, standing for "perixosome proliferator-activated receptor," which entered the limelight earlier this month as a result of a ruling from an outfit known by yet another acronym: the FDA. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription